Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population

Although prostate biopsy is the gold standard for the diagnosis of prostate cancer, it also leads to high incidence of negative biopsies and the diagnosis of clinically low-risk prostate cancer and the subsequent overtreatment. It remains an unmet need to discover new biomarkers in order to defer th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lie-Fu, He, Sha, Wu, Xiaopei, Jiang, Shengying, Zhang, Ruo-Chen, Yang, Ze-Song, Chen, Fa-Wen, Pan, Dan-Ling, Li, Dong, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013283/
https://www.ncbi.nlm.nih.gov/pubmed/32099679
http://dx.doi.org/10.1155/2020/3964615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013283/
https://www.ncbi.nlm.nih.gov/pubmed/32099679
http://dx.doi.org/10.1155/2020/3964615

Ejemplares similares